This is the first stage in the regulatory process which will determine if and which peptide substances may become available for compounding, and indirectly also guide future scientific research and investment, all in helping to shape patient access for years to come
Typical TB500 Dosing Schedule Loading Phase (Weeks 14): Dosage: 48 mg per week Frequency: Split into 2 injections per week (e.g., Monday/Thursday) Goal: Rapid saturation of soft tissue to initiate repair Maintenance Phase (Weeks 58 or longer): Dosage: 26 mg per month Frequency: 1 injection every 714 days Goal: Support long-term recovery and tissue integrity Users typically adjust their dose based on: Injury severity Body weight Co-administration with BPC157 or other peptides Note: These guidelines are based on research chemical protocols and anecdotal data
However, intravenous administration of synthetic DSIP in 6 middle-aged human chronic insomniacs with disturbed sleep brought very good results, as longer sleep, higher quality with fewer interruptions and slightly more REM sleep
Similar matrix remodeling effects have been observed with other regenerative peptides including BPC-157 and TB-500, though through distinct molecular mechanisms
These are studies of regulation, signaling, and long-term systemic management
